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Case Presentation
An 11-year-old Caucasian boy presented to our der-
matology clinic with a 1-year history of a mildly pru-
ritic, scaly, erythematous, edematous plaque involving
the entire penis and scrotum. Potassium hydroxide
preparation was negative for fungi. Clinical impression
at that time was psoriasis, and he improved somewhat
with topical corticosteroids, but over the next 2 years,
he developed more nontender edema and erythema of
the scrotum and the penis. He remained otherwise
healthy without any fever, chills, or weight loss. Family
history was positive for psoriasis and eczema.
Physical examination of the groin and genitalia
revealed scrotal and penile edema and erythema with-
out increased warmth or signs of infection. Overlying
the erythema were multiple scaly papules extending
from the distal shaft of the penis to the scrotum and
then under the raphe and up the gluteal cleft (Figs. 1
and2). The rest of skin examinationwasunremarkable.
A 4-mm punch biopsy of the scrotum was per-
formed. The histopathologic features are illustrated in
Figs. 3 and 4.
What is the diagnosis?
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Case Presentation
An ill-appearing 12-year-old boy was hospitalized in
April with a 4-day history of fever, severe headaches,
neck pain, photophobia, andmalaise. There were 40 to
50 erythematous papules and vesicles scattered on his
face, torso, and extremities (Fig. 1) and two tender
2- by 1-cm inflammatory nodules with necrotic eschars
on his back (Fig. 2). No enanthem or regional
lymphadenopathy were noted. Routine bacterial and
viral cultures of cerebral spinal fluid (CSF), blood, and
one of the necrotic skin lesions on the back were
negative. Polymerase chain reaction of CSF and skin
for herpes simplex virus and varicella-zoster virus were
also negative. A biopsy of one of the ulceronecrotic
nodules on his back was obtained, which showed a
focal epidermal ulceration associated with ballooning
degeneration of keratinocytes, necrosis of the epider-
mis, and a mixed band-like predominantly lympho-
histiocytic inflammatory infiltrate adjacent to the
epidermis in addition to superficial and deep perivas-
cular lymphohistiocytic inflammation. Prominent
papillary dermal edema and focal areas of vascular
damage were also noted (Fig. 3). Additional history
revealed that a pet gerbil had died from unknown
causes 2 days after the onset of the patient’s symp-
toms. There was no known infestation of the patient’s
home by mice or other rodents. There were no other
household pets and no known exposures to fleas,
mites, or ticks. The patient had no history of recent
travel outside of the Philadelphia area.
What is the diagnosis?
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Case Presentation
A5-year-old girl presented to our dermatology clinic at
OregonHealth and ScienceUniversity for consultation
regarding erythemaand edemaof the right ear. Shewas
otherwise healthy. Her mother had first noted the right
superior helix to be ‘‘red and swollen’’ 4 months before.
At that point, her primary care provider had treatedher
with antibiotic eardrops for suspected otitis externa,
without improvement. The otolaryngology service next
evaluated her and treated her with a 10-day course of
prednisone and cephalexin. She had no response to this
treatment either. Over the ensuingmonths, the affected
area extended to involve the entire helix and earlobe.
The areawas initially tender but became asymptomatic
after the first month. She had no other symptoms,
specifically, no fever, weight loss, arthralgia, myalgia,
or other cutaneous lesions.
She did not have a history of trauma, recent ill-
ness, or medications before development of the erup-
tion. She had unremarkable past medical and family
histories. She patient had lived in the United States her
entire life. She had traveled to the Lake Constance
regionofGermany for a vacationwithhermother a few
weeks before onset of the current illness.
Physical examination revealed the patient to be
afebrile andwell appearing. The right ear, from helix to
earlobe, was brightly erythematous and warm with
firm, nonpitting edema (Fig. 1). Therewasnooverlying
epidermal change. The remainder of the cutaneous
examination was unremarkable. Incisional biopsy of
the helical rim was performed (Figs. 2 and 3).
What is the diagnosis?
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Histologic examination of the skin biopsy at 4· mag-
nification revealed a patchy, moderately dense inter-
stitial infiltrate consisting of lymphocytes, plasma cells,
and histiocytes. At 40· magnification, the lymphocytes
were observed to be large, with prominent, irregular
nuclei.
Discussion
At follow-up visit, enzyme-linked immunosorbent as-
say (ELISA) and Western blot were performed for
suspected Borrelia lymphocytoma, and she was
empirically started on amoxicillin 50 mg ⁄kg per day
divided into three doses for 3 weeks. The ELISA was
positive for Borrelia antibody (2.07; positive is >1.21),
and Western blot IgG was positive with six bands.
Immunoglobulin (Ig)M was negative. The erythema
and edemaofher ear improveddramatically toward the
end of her 3-week antibiotic course. At follow-up
2 months later, the ear appeared normal.
Borrelia lymphocytoma occurs predominantly in
Europe (1). Cases of Borrelia-associated lymphocy-
toma may be underreported and underrecognized,
especially in children (2). Borrelia afzelii and Borrelia
garinii are the major causes of European lymphocy-
toma (3,4). These species are not seen in the United
States, where the only recognized pathogenic species is
Borrelia burgdorferi sensu stricto. Lyme borreliosis is
rare in Oregon, with only 71 locally acquired cases re-
ported from 1999 to 2004 (5).
In children, Borrelia lymphocytoma occurs most
often on the ear. Breast involvement is less common
than in adults (2).Many patients do not recall tick bites
in these locations. It has been suggested that Borrelia
spirochetes may have tropism for cooler body sites (6).
Lyme borreliosis may have up to three stages: stage 1 is
mainly lymphocutaneous involvement; stage 2 results
from systemic spread to the nervous, cardiac, and
musculoskeletal systems; and stage 3 refers to late se-
quelae. Lymphocytoma occurs during the second stage
of the disease. In anAustrian study of nine patients, the
average interval between tick bite and lymphocytoma
was 5.5 weeks (7). Fortunately, despite occurring dur-
ing the systemic stage, lymphocytoma is rarely associ-
ated with extracutaneous symptoms (8).
Borrelia culture is difficult, and polymerase chain
reaction for direct detection of Borrelia organisms is
not sensitive or economical, but serologic testing can
help detect cases of Borrelia lymphocytoma. The two-
tier test protocol, starting with ELISA and then
immunoblotting, is recommended for investigation of
suspectedLymeborreliosis (9).Westernblot is themost
specific study.
The Centers for Disease Control and Prevention
and U.S. and German associations for pediatric infec-
tious disease recommend treatment for Borrelia
lymphocytomawith oral amoxicillin 50 mg ⁄kg per day
for children younger than 9 or oral doxycycline 100 mg
twice a day for older children for 14 to 21 days.
References
1. Frithz A, Lagerholm B. Acrodermatitis chronic atrophicans,
erythema migrans and lymphadenosis benigna cutis: spiro-
chetal diseases? Acta Dermatol Venereol 1983;63:432–436.
2. Pohl-Koppe A, Wilske B, Weiss M et al. Borrelia lymphocytoma
in childhood. Pediatr Infect Dis J 1998;17:423–426.
3. Lenormand C, Jaulhac B, De Martino S et al. Species of Borrelia
burgdorferi complex that cause borrelial lymphocytoma in
France. Br J Dermatol 2009;161:174–176.
4. Busch U, Hizo-Teufel C, Bohmer R et al. Borrelia burgdorferi
sensu lato strains isolated from cutaneous Lyme borreliosis
differentiated by pulsed-field gel electrophoresis. Scand J Infect
Dis 1996;28:583–589.
5. Doggett JS, Kohlhepp S, Gresbrink R. Lyme disease in Oregon.
J Clin Microbiol 2008;46:2115–2118.
6. Colli C, Leinweber B, Mullegger R et al. Borrelia burgdorferi-
associated lymphocytoma cutis: clinicopathologic, immunophe-
notypic, and molecular study of 106 cases. J Cutan Pathol
2004;31:232–240.
7. Plorer A, Sepp N, Schmutzhard E et al. Effects of adequate
versus inadequate treatment of cutaneous manifestations of
Lyme borreliosis on the incidence of late complications and late
serologic status. J Invest Dermatol 1993;100:103–109.
8. Asbrink E, Howmark A. Early and late cutaneous manifestations
in Ixodes-borne borreliosis (erythema migrans borreliosis, Lyme
borreliosis). Ann N Y Acad Sci 1988;4:152.
9. Stanek G, Strle F. Lyme borreliosis: a European perspective on
diagnosis and clinical management. Curr Opin Infect Dis 2009;
22:450–454.
Address correspondence toSabraLofgren,M.D., 3303SWBondAve
CH16D, Portland, OR 97239, or e-mail: lofgren@ohsu.edu.
Diagnosis: Granulomatous lymphangitis
(a variant of cutaneous Crohn disease)
Microscopic Findings, Additional
Studies, and Clinical Follow-Up
Histopathologic evaluation revealed psoriasiform
acanthosis of the epidermis and a diminished granular
cell layer. A collection of epithelioid histiocytes and
giant cells with central fibrinoid necrosis was present
within the upper dermis. Granulomas were also noted
in the deep lymphatics. Periodic acid Schiff and acid-
fast bacilli stains were negative.
The boy was referred to a gastroenterologist, and
esophagogastroduodenoscopy and colonoscopy with
biopsies revealed no evidence of active ileitis or colitis.
Rectal biopsies revealed isolated microgranulomas.
Laboratory studies showed high anti-Saccharomyces
cerevisiae antibodies (ASCA) immunoglobulin (Ig)G
and IgA titers. Tuberculin test and chest radiograph
were normal. The gastroenterologist’s conclusion was
metastatic (cutaneous) Crohn disease (CD). Twice
monthly adalimumab injections were started, and the
penile and scrotal swelling improved dramatically
within 9 months. The boy continued to feel well,
without any gastrointestinal symptoms related to CD.
Further review of the case and slides with the identifi-
cation of granulomas in the lymphatics led us to the
diagnosis of granulomatous lymphangitis (GL).
Discussion
Genital edema is a rare condition that is most com-
monly benign and self-limited. In children, it is usually
idiopathic and thought to be a localized variant of an-
gioedema (1), but the persistence of scrotal and penile
swelling and the presence of granulomatous inflam-
mation points to GL, a rare cause of genital swelling in
children. GL is associated with concurrent or sub-
sequent development of CD and is histopathologically
indistinguishable from CD (1,2). Hence, it is often re-
ferred to as a variant of cutaneous Crohn disease (GL-
CCD) (1).
Granulomas ofCDcanoccur at sites distant from
the gastrointestinal tract, particularly the skin (3). Skin
lesions appear more commonly when CD involves the
colon than the ileum alone (4). When involving the
anogenital area, this canpresent as nontender erythema
and swelling of the penis or the vulva (2). The swelling is
thought to be secondary to lymphedema as a result of
inflammation involving the lymph vessels and sub-
sequent lymphatic obstruction (1).
Histologically, GL-CCD is characterized by dis-
crete, noncaseating granulomas with numerous Lan-
gerhans-type multinucleated giant cells present in the
superficial and deep dermis and the adipose tissues.
Perivascular or perifollicular accentuation and extra-
vascular neutrophilia are often present as well (4). The
presence of granulomas within lymphatics is the
essential feature of granulomatous lymphangitis (1).
Granulomatous lymphangitis-cutaneous Crohn
disease affects boys and girls equally, with a reported
age of onset of 10 to 14 years (4). The most common
presentation of GL-CCD in children is genital
involvement, with swelling and induration of the geni-
tals with or without erythema in 85% of reported cases
(4). Only 47.5% of children diagnosed with GL-CCD
have a concurrent diagnosis of CD, but 42.5% sub-
sequently develop CDwithin 9 months to 14 years (4).
Therefore, clinical and laboratory examinations should
be performed to look for evidence of CD at the time of
presentation, as well as during follow-up for future
development, although 7.5% of cases do not develop
any signs of CD and may represent a forme fruste of
CD (1).
Patients with suspected GL-CCD require a care-
ful diagnostic evaluation (5). Biopsies of the affected
area should be obtained for histologic examination and
special staining for acid-fast bacilli and fungi (5).
Additional investigations include complete blood
count, erythrocyte sedimentation rate, ASCA Ig, chest
radiograph, and a tuberculin test (5). Esophagogas-
troduodenoscopy and colonoscopy with biopsies
should be performed to look for evidence of CD.
Treatment options include topical and oral corticos-
teroids; chemotherapeutic agents such as azathioprine,
cyclosporin, and sulfasalazine; and biological agents
such as infliximab and adalimumab (4).
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Diagnosis: Rickettsialpox
Further Investigations and Course
Empiric doxycycline was started with rapid clinical
improvement. The skin biopsy specimenwas sent to the
Centers for Disease Control and Prevention (CDC),
where an immunohistochemical stain to spotted fever
group rickettsia (SFGR) was positive (Fig. 4). A con-
valescent serum specimen demonstrated seroconver-
sion with immunoglobulin (Ig)G antibodies reactive to
SFGR antigens (1:256).
Discussion
The obligate intracellular bacteria Rickettsia akari
causes rickettsialpox, which is transmitted to humans
through thebite of thehousemousemite (Liponyssoides
sanguineus). The house mouse, Mus musculus, is con-
sidered to be the natural vertebrate reservoir for
R. akari. The house mouse mite has also been isolated
from other rodent species, including gerbils (1). Sero-
logic evidence of infection withR. akari has been noted
in other rodent species but to our knowledge not in
gerbils.
After an incubation period of 9 to 14 days, an
indurated, ulcerated papule or nodule with eschar
forms at the site of the bite; two primary lesions with
escharmay be seen (2,3). A generalized papulovesicular
eruption that typically spares the palms and soles then
occurs. Fever, headache, malaise, and leukopenia are
common, and neck pain, photophobia, and a vesicular
enanthem involving the oral mucosa are described
occasionally.
Diagnosis may be made by demonstrating the
development of convalescent antibodies to the SFGR.
Specialized reference laboratories, including the CDC,
can perform immunohistochemical SFGR staining on
skin biopsy specimens (4). Of the spotted fever group
rickettsioses, only rickettsialpox is considered endemic
to urban centers of the northeastern United States.
Other eschar-associated spotted fever group rickettsi-
oses endemic to the United States include Rickettsia
parkeri rickettsiosis in the southeast and Rickettsia
364D rickettsiosis in California (5).
The differential diagnosis of rickettsialpox in-
cludes varicella, coxsackievirus A16 and other entero-
viral infections, infectiousmononucleosis, disseminated
herpes simplex, and gonococcemia. When only the
primary inoculation lesion is clinically apparent, the
differential diagnosis includes other infectious causes of
eschars, including cutaneous anthrax, bacterial ec-
thyma, and cutaneous mucormycosis or aspergillosis,
and noninfectious conditions such as spider bites.
The treatment of choice for rickettsialpox is
doxycycline for 5 to 10 days; rapid and complete
recovery is expected, although symptoms in untreated
patients also resolve within 10 to 14 days.
Although themajority of cases of rickettsialpox in
theUnitedStates havebeen reported inNewYorkCity,
some have come from other cities, predominantly
larger urban areas (6). During 2001, an increase in the
number of reported cases in New York City was seen
after the identification of several cases of bioterrorism-
associated cutaneous anthrax (7). To our knowledge,
this is the first case of rickettsialpox reported from
Philadelphia since 1952 (8).
Rickettsialpox is probably underrecognized be-
cause most cases present with mild, self-limited symp-
toms, but patients may also present with clinical
findings suggestive of a more serious infection. Recog-
nitionof the cutaneous eschar andpapulovesicular rash
andahigh indexof suspicion inmetropolitanareaswith
large rodent populations is paramount to making the
diagnosis.
The findings and conclusions in this report are
those of the authors and do not necessarily represent
the official position of the Centers for Disease Control
and Prevention.
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Figure 4.
AN ERYTHEMATOUS EAR
AN ADOLESCENT BOY WITH PERSISTENT PENILE AND SCROTAL
ERYTHEMA AND SWELLING
FEBRILE ILLNESS WITH PAPULAR AND VESICULAR EXANTHEM AND
ULCERONECROTIC PLAQUES
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